South Africa paying more than double EU price for Oxford-AstraZeneca’s vaccine

- Advertisement -

PRETORIA, South Africa (CU)_South Africa will have to purchase doses of Oxford-AstraZeneca’s COVID-19 vaccine at a price more than 2 times higher than most European countries, the country’s health minister says.

South Africa, the worst-hit country in the continent, has ordered 1.5m doses of the vaccine from the Serum Institute of India (SII), which according to a senior health official, would cost $5.25 (€4.32) per dose, nearly 2.5 times the amount paid by European nations.

Previously, a Belgian minister leaked it on Twitter that the European Union members purchase the vaccine at $2.16 (€1.78) each. Although AstraZeneca France has said that its shots would be capped at €2.50 (around $3) per dose, the company has not yet responded to the claims made by South Africa.

According to Anban Pillay, South Africa’s deputy director general of health, a lower price was quoted to European countries since they contributed to the vaccine’s research and development. “The explanation we were given for why other high-income countries have a lower price is that they have invested in the [research and development], hence the discount on the price,” Pillay said.

However, it is noteworthy that around 2,000 South Africans participated in clinical trials for the vaccine last year.

Meanwhile, the World Health Organization (WHO) has warned against “vaccine nationalism” and “price gouging”, as the agency says deals between wealthier nations and vaccine manufacturers have raised concern over price rises.

South Africa is currently battling with a second wave of infections fuelled by a new and more transmissible COVID-19 variant discovered in the country. According to the country’s Ministry of Health, South Africa has registered more than 1.38 million COVID-19 infections and 39,500 virus-induced deaths, since the beginning of the pandemic.

The government aims to vaccinate two-thirds of its population of nearly 60 million people, in order to achieve herd immunity by the end of 2021.

A Personal Note from the Publisher" Small photo of you, with your signature beneath

A Personal Note from the Publisher

My dear friend, thank you for your time with us today. This site was built for you, the members of the Commonwealth Family, and nothing matters more to me than hearing your voice and feedback.

What did you make of this article? Did it inform you, challenge you, or leave you wanting more?

Please tell me. I read your replies personally and they help shape everything we publish.

With warmest wishes,
Hon. Nirj Deva
Founder and Publisher.

Free, always. We'll never sell your details.

spot_img

Hot this week

India’s Gold Revolution: You Can Now Own Gold Without Ever Holding It—What Is Changing?

MUMBAI, INDIA — 20 NOVEMBER 2026 People in India have...

Malta’s New Tourist Tax Set to Exceed Rates in Competing Mediterranean Destinations

Travellers planning a holiday in Malta will soon face...

TSMC Tightens Chip Manufacturing Rules for Chinese Companies After New US Export Controls

The world’s largest contract chipmaker, Taiwan Semiconductor Manufacturing Co...

Jamaica and the United States Sign Customs Agreement to Bolster Border Security

Jamaica and the United States have signed a new...

The Flight Was Over, But the Danger Wasn’t: Why Two Virgin Australia Pilots Refused to Fly Again

ADELAIDE, AUSTRALIA — 20 NOVEMBER 2026 It is possible for...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories